Mechanisms in Innovation in Vascular Disease

项目描述（申请人提供）：该项目每年将培养6名博士后研究员，研究血管疾病的机制和创新。该计划的目标包括科学方法，批判性分析，逻辑推理和独立思考的严格培训，所有这些都在一个高度协作的工作组中进行。学员将开发一个转化血管研究专业知识的重点领域，并将接触到广泛的互补研究技术。导师将提供合议和富有成效的合作，并帮助磨练口头和书面沟通的技能，并灌输尊重负责任的研究行为。研究员将接受一个 至少两年的教育和研究计划，虽然我们只打算通过机构T32资助第一年。将鼓励和指导研究员拟订第二年的供资提案。该计划的总体目标是培养在血管疾病的基本问题上受过良好教育的研究人员，并致力于寻找创新策略来解决这些问题，从而将基础研究转化为临床成功。研究员将在血管生物学和疾病的基础，转化和临床研究的多学科环境中接受培训。斯坦福大学心血管研究所（CVI）提供了一个独特的平台，通过它来培养下一代的基础和转化科学家。该计划的导师，CVI的所有成员，不仅来自血管医学，而且来自材料科学，生物工程，成像和健康研究和政策。这些科学家聚集在一个合作研究所，对血管发育和疾病背后的机制有着共同的兴趣。

DESCRIPTION (provided by applicant): This program will train 6 postdoctoral fellows annually in mechanisms and Innovation in vascular disease. The program goals include rigorous training in the scientific method, critical analysis, logical reasoning and independent thinking, all within a highly collaborative working group. Trainees will develop a focused area of translational vascular research expertise and will be exposed to a wide range of complementary research techniques. Mentors will provide collegial and productive collaboration, and help to hone skills in oral and written communication, and to instill respect for the responsible conduct of research. Fellows will undergo a minimum two-year education and research program, although we only intend to fund the first year through the institutional T32. Fellows will be encouraged and mentored in their development of funding proposals for the second year. The overarching goal for this program is to produce researchers who are well-schooled in the fundamental problems of vascular disease, and are driven to find innovative strategies to tackle those problems, thereby translating basic research into clinical success. Fellows will receive their training in a multidisciplinary milieu of fundamental, translational and clinical research in vascular biology and disease. The Stanford Cardiovascular Institute (CVI) offers a unique platform by which to train the next generation of basic and translational scientists. Mentors for the proposed program, all members of the CVI, come not only from vascular medicine, but also from materials science, bioengineering, imaging, and health research and policy. Brought together in a collaborative Institute, these scientists share a common interest in the mechanisms behind vascular development and disease.